0R2M
Regeneron Pharmaceuticals, Inc. · LSE:0R2M
962.93 USD43.42 +4.72%
Regeneron Pharmaceuticals, Inc. (LSE:0R2M) last traded at 962.93 USD, up 4.72% on the day. Over the past year the stock is up 47.23%. Its 52-week range is 591.60 to 973.87. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open923.11
Day range913.54 – 973.87
52-week range591.60 – 973.87
Volume1.61 K
Average volume (10 days)698
Market cap95.51 B
P/E21.26
EPS (TTM)45.30
Dividend yield0.40%
Beta (1 year)0.4642
Revenue (TTM)16.90 B
Employees15.41 K
Performance
+19.03%1 week
+30.83%1 month
+27.82%3 months
+37.76%6 months
+24.65%Year to date
+47.23%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Regeneron Pharma Price Target Raised to $812.00/Share From $756.00 by BernsteinDow Jones Newswires · 02 Nov 2026
- Bernstein maintains Regeneron Pharmaceuticals at Market Perform, raises price target to $812 from $756TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
- Truist Securities maintains Regeneron Pharmaceuticals at Buy, raises price target to $982 from $780TradingView · 02 Nov 2026
- RBC Capital maintains Regeneron Pharmaceuticals at Sector Perform, raises price target to $913 from $810TradingView · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.